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Much of the information on the health effects of radiation exposure available to date comes from
long-term studies of the atomic bombings in Hiroshima and Nagasaki. Accidental exposures, such
as those resulting from the Chernobyl and Kyshtym accidents, have as yet provided little informa-
tion concerning health effects of ionizing radiation. This paper will present the current state of our
knowledge concerning radiation effects, review major large-scale accidental radiation exposures,
and discuss information that could be obtained from studies of accidental exposures and the
types of studies that are needed. Environ Health Perspect 104(Suppl 3):643-649 (1996)
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Introduction
Ionizing radiation is one ofthe agents in
our environment for which genetic and
cancer risks have been best studied and
characterized to date. This is mainly due to
two facts: large populations have been
exposed and followed for decades and,
compared to many other environmental
agents, radiation exposures are relatively
easy to reconstruct on an individual level, at
least for exposures received at high exposure
rates and high levels.
The information available to date on
radiation risks comes from several sources.
Epidemiological studies oflarge populations
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that have received relatively high doses of
yor X radiation at a high dose rate (atomic
bomb survivors, patients treated by radio-
therapy for malignant or benign diseases,
occupational exposures in the early years of
medical exposures) or high doses ofa parti-
des in a protracted fashion over manyyears
(hard rock, particularly uranium, miners)
have been carried out (1-3). More recently,
there have also been large-scale epidemio-
logical studies of populations that have
received low doses in a protracted fashion
as a result of occupation, mainly in the
nuclear industry (2,4,5). Large-scale animal
experiments have been carried out in order
to understand the effects ofdifferent radia-
tion types, exposure levels, patterns ofexpo-
sure, and modifying factors (1-3). There
have also been cytogenetic, molecular, and
genetic studies aimed at understanding
the mechanisms of radiation-induced
carcinogenesis (1,6).
Nonroutine environmental exposure to
ionizing radiation oflarge populations has
occurred through accidents but also
through acts ofwar and war-related activi-
ties. Such exposures can be divided into
two types: those that affect only a limited
number ofpersons (mainly workers at the
location of the accident) and those that
involve large groups ofthe general popula-
tion. Accidents limited to a few exposed
persons are much more frequent than those
yielding global environmental contamina-
tion and may go unreported. Most ofthe
known accidents resulted in relatively high
doses to small numbers of persons (7).
Table 1 summarizes the main events that
have resulted in large-scale radiation expo-
sures. They vary substantially in terms of
the size ofthe populations exposed and the
level and type ofexposures. Most ofthese
have as yet provided little information con-
cerning the carcinogenic and genetic effects
ofionizing radiation. The exception is the
study ofsurvivors ofthe atomic bombings
in Hiroshima and Nagasaki, which is the
primary basis for radiation protection for
Xand yradiation today.
Current Basisfor Radiation
Risk Estimates-The Atomic
Bomb Survivors Study
Background
On 6 August and 9 August 1945, respec-
tively, atomic bombs were dropped on the
cities ofHiroshima and Nagasaki in Japan,
bringing about, in a matter of days, the
end of the Second World War in the
Pacific. The bombs, by today's standards,
were small, with yields between 10 and 20
kT oftrinitrotoluene (TNT). Most ofthe
resulting exposure was to y rays and to
some neutrons, and most of the dose to
those who were in the cities at the time of
the bombingwas almost instantaneous (8).
Follow-up ofthe health ofthe survivors
started soon after the bombings; however,
it was not until 1950, at the time of the
national census, that an exhaustive list of
the survivors was made by introducing a
question in the census questionnaire con-
cerning presence in Hiroshima or Nagasaki
at the time ofthe bombings (12). Among
the 195,000 survivors thus identified, a
random sample of approximately 99,000,
stratified on distance from the epicenter,
and a sample of 26,000 who were not in
the city were drawn in the early 1950s-
the Life Span Study sample-and have
been followed since then for mortality and
cancer incidence. Subsamples ofthis popu-
lation were drawn for clinical and repro-
ductive history follow-up, and a sample of
the offspring ofthe survivors was drawn for
genetic follow-up.
Individual radiation dose was recon-
structed for members ofthe Life Span Study
and for children in utero at the time ofthe
bombing, taking into account the location
and position ofthe subjects at the moment
of the bombing, the shielding situation,
the weather, and results of atmospheric
weapons tests and leakage experiments.
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Doses among the study subjects ranged
from 0 up to 6 Gy; the distribution ofdoses
was skewed, with the majority ofsurvivors
receiving less than 200 mGy. In all, about
12,500 persons received doses of 1 Gy or
above (9), and those tended to be the sub-
jects who were closest to the epicenters.
Several versions ofthe dose estimates have
been derived over time. Those currently
used are based on the Dosimetry System 86
(DS86) (8). The neutron component ofthe
dose is currently being reevaluated (13),
but this is unlikely to have a substantial
impact on the risk estimates (14).
Because ofthe size ofthe exposed popu-
lation, the availability of individual dose
estimates, and the distribution ofages and
sexes in the population of survivors, the
Life Span Study is at present the most
informative single study ofradiation effects;
it is the main basis for radiation risk esti-
mates and radiation protection standards
today (1,2,15,16).
Table 1. Characteristics of main large-scale accidental or nonroutine radiation exposures.
Number of
Name (reference) Location Exposure circumstances Date exposed persons Exposure type Dose estimate
Hiroshima and Japan War, atomic bombing 1945 195,000 Whole bodyto
76,000afollowed
Kyshtym (6,10) Southern Urals:
Chelyabinsk,
Sverdlovsk, and
Tyumensk Provinces
Accidental exposuresfrom
thermonuclear test
Explosion of radioactive
waste storage tank
Southern Urals Routine discharge of radio-
chemical production waste in
river basin and lake
1954 267 on atolls
23 on fishing boat
1957 270,000
10,200 evacuated
1949-1956 124,000 on river banks
7,500 evacuated
between 1953-1960
Resuspension of materials
deposited in silts of lake
Release of radioactive iodine
1967 41,500
1944-1947 270,000
1,400 mostexposedd
60Co radiotherapy head opened 1983-1984
Windscale (6) United Kingdom Fire in reactor
Three Mile Island (6) United States
Chernobyl (6,11) Ukraine
,yand neutrons
Whole body, to
yand 3
Thyroid to 1311
Whole body
Whole body y rays
Internal
Whole bodytoy
Internal to °Sr,
89sr, 137Cs
Marrow
External
Thyroid to 1311
4,000
1957
Human errors in power reactor 1978
Destruction of reactor core 1986 135,000 evacuees
from 30 km zone
270,000 in strict
control zones
600,000 clean-up
workers
Radiotherapy device opened
75 million in European
part of USSR
1987 200 evacuated
129 exposed
Thyroid
Population within
80 km to external y
Whole bodytoyrays
Thyroid to 1311,
children
CEDEfrom yrays
Thyroid to 1311,
children
Range =0-6 Gy
Average = 0.16 Gy
2,500 persons, >1 Gy
Range = 1-2 Gy
Range = 3-15 Gy
Range = 2-6 Gy
Range = 0-600 mSv
Range = 0-520 mSv
Average CEDEb
5-600 mSv
7,300 persons, = 600 mSv
Total average
marrow dose:
Range =0-4 Gy
2,000>1 Gy
Range
AEDE = 35-1,700 mSv
Range = 0-4,000 mSv
4,800 = 13 mSv
Rest =7 mSv
95% <0.3 Gy
Range = 0.15-6.5 Gy
Median = 0.7 Gy
700 persons, 0.005-0.25 Gy
80 persons, 0.25+ Gy
5 persons, 3-7 Gy
<1 mSv
100-2500 pSv
Average = 15 pSv
Maximum = 850 pSv
Range = 30-500+ mSv
Average = 120 mSv
Average = 0.3 Gy
Range = 0.1->2.5 Gy
Average = 60 mSv
4%,>100mSv
800 persons, >200 mSv
Range = 0.1->10 Gy
45%, <100 mSv
47%, 100-250 mSv
0.02%, >500 mSv
Total average
CEDE =6-7 mSv
Whole bodytoy Range = 0-5.3 Sv
Environmental Health Perspectives * Vol 104, Supplement 3 * May 1996
Nagasaki (9,10)
Marshall Islands,
Bikini atoll (6)
Pacific Ocean
Techa River, Lake
Karachay (6,10)
Hanfordc
Juarez(6)
Washington
State
Mexico
Goiania Brazil
AEDE, annual effective dose equivalent. aLife Span Study cohort with DS86 dose estimates (9). bCommitted effective dose equivalent estimated for the 30 years after the
accident. cPersonal communication. dInfants and children drinking milkfrom cows in pasture.
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Results
The early effects of the bombings have
been extensively described: they included
thermal, mechanical, and radiation (in
particular radiation-induced bone-marrow
depletion) injuries (17). Late effects
observed among the survivors were cataracts
(18) and increased cancer risk (9), as well
as microcephalia and mental retardation in
those exposed in utero (19). There was no
apparent effect on life shortening and aging
(20) and on the incidence of most non-
cancerous diseases (21). There was also no
evidence ofgenetic effects (22,23).
Among cancers, the first increase was
observed in leukemia mortality, which
peaked in the period between 1950 and
1954 (9). Increases were observed for all
leukemia subtypes except chronic lympho-
cytic leukemia (CLL) (24), a disease virtu-
ally unknown in Japan, and adult T-cell
leukemia. Although the relative risk has
decreased since then, it is still significantly
elevated (24). The increased leukemia risk
was the main long-term effect ofradiation
observed until 1970. Leukemia mortality is
best described by a linear excess relative
risk model ofthe form:
RR= 1 + Wat5ath(e)d
where d denotes the radiation dose,
t attained age, e the age at exposure and
s the sex of the subject (1,25). In such a
model, the relative risk and the latent
period are functions ofage at exposure and
ofdose: indeed, the relative risk was high-
est and the latent period shortest for those
who were children at the time of the
bombing. Likewise, most other epidemio-
logical studies have shown an increased risk
ofleukemia, starting shortly (2-5 years)
after exposure (1,2).
From 1974 onward, a rapid increase in
mortality from solid cancers became observ-
able (25% in the period 1974-1978);
significant increases were observed for can-
cers of the esophagus, stomach, colon,
lung, female breast, ovary, urinary tract,
and multiple myeloma (9). A significant
increase in thyroid cancer incidence was
also observed (26).
Solid cancer mortality is best described
by a linear excess relative risk model of
the form:
RR= 1 +Pas6Ced
where ddenotes the radiation dose, e the
age at exposure (for breast cancer only) and
s the sex of the subject (25,27). In this
model, the cancer mortality among the
exposed is proportional to that of the
nonexposed and the latent period is
independent ofdose and age at exposure.
It is noteworthy that the total number
of cancer deaths attributable to radiation
among the atomic bomb survivors is rela-
tively small: about 10% ofthe 6,000 solid
cancer deaths and 55% of the 200 leu-
kemia deaths observed to the end of 1985
(9). In the higher dose categories, however,
most ofthe cancer deaths are attributable
to radiation exposure. Despite this fact,
this study is the most informative single
study on radiation effects in humans. Ifno
effort had been made to carry out a com-
plete and systematic individual follow-up
ofthe Life Span Study cohort with individ-
ual dose reconstruction, it may have been
verydifficult to detect the excess cancer risk.
Open Questions in Radiation
Protection: What Can Be
Learned from Other
Exposure Circumstances?
Radiation protection today is primarily
concerned with low-dose protracted expo-
sures to ionizing radiation (such as are
received by the general population from
environmental sources or by occupational
groups from their work with radiation),
with host and environmental factors that
may modify radiation-induced risks and
with the effect ofdifferent types of radia-
tion. The study of atomic bomb survivors
alone cannot provide information to
answer these questions for several reasons:
* Because of the nature of the exposure,
the follow-up ofthe atomic bomb sur-
vivors provides little information on the
risk related to low doses-of the order
of 0.1 to 0.2 Gy-and no information
on the effect ofexposure protraction.
* The study population may be a selected
sample of all survivors present in
Hiroshima and Nagasaki at the time of
the bombings because it was identified
from a list ofthose alive in 1950. How
large an impact this initial selection
effect may have on the estimation of
cancer risk 40 to 50 years after the
bombing is a subject ofdebate.
* The study subjects are Japanese,
exposed during wartime. It is possible
that host and environmental factors
modify the risk of radiation-induced
cancer; thus, the choice of model to
extrapolate risk estimates to popu-
lations with different background
incidence and mortality rates ofcancer
is uncertain.
* The size ofthe study population is still
small for the study of relatively rare
malignancies.
It is therefore important to obtain
complementary information on radiation
risks from the study of other populations
with different patterns of radiation expo-
sure and different host and environmental
characteristics. Studies oflarge numbers of
patients irradiated for therapeutic purposes
(for cancer or benign diseases) in Western
Europe, North America and Israel have
been carried out [for a detailed review, see
(1,2)]. Overall, the results ofthese studies
are consistent with those of the atomic
bomb survivors, although studies ofsecond
cancer risk among patients having received
radiotherapy for a first cancer appear to
indicate a slightly lower risk ofcancer per
unit ofradiation dose (28).
To extrapolate risks to exposure situa-
tions resulting in low doses received in a
protracted fashion, most committees and
regulatory bodies have chosen to divide
estimates derived by linear extrapolation
from atomic bomb survivors data by a fac-
tor ranging from 2 to 5, the dose/dose-rate
effectiveness factor (DDREF), to account
for the sparing effect of exposure protrac-
tion (1,2,15,16). There is much contro-
versy about the appropriateness of this
approach, however, with some scientists
claiming that risks are in fact much higher
and others that protracted low-dose expo-
sures may reduce the risk ofcancer. Studies
of populations having received low-dose,
low dose-rate exposures are now providing
direct estimates ofriskfrom such exposures.
DirectEstimatesoftheEffes ofLow
Doses andDoseRates- Studies of
NudearWorkers
Studies of cancer risk among workers
in the nuclear industry around the world
are particularly well suited for the direct
estimation of the effects oflow doses and
dose rates of ionizing radiation. This is
because large numbers ofworkers have
been employed by this industry since its
beginning in the early to mid-1940s,
because these populations are relatively sta-
ble, and because, by law, individual real-
time monitoring of potentially exposed
personnel has been carried out in most
countries, at least for external higher energy
exposures, and the measurements have
been kept.
Published studies have covered cohorts
of nuclear industry workers in the United
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States, the United Kingdom, and Canada
(29-54). Most of these studies have
provided little evidence of dose-related
increases in all cancer mortality, although
statistically significant associations between
mortality from all cancers combined and
cumulative radiation dose were observed
in two studies of Oak Ridge National
Laboratory employees in the United States
(49) and of the employees ofthe Atomic
Weapons Establishment in the United
Kingdom (40). The statistical power of
individual studies was, however, lowand in
most cohorts the confidence intervals of
the risk estimates were compatible with a
range ofpossibilities, from negative effects
to risks an order ofmagnitude greater than
those on which current radiation protec-
tion recommendations are based. Com-
bined analyses ofdata from some ofthese
studies have therefore been carried out
at the national and international levels
(4,5,55-57) specifically to test the adequacy
ofexisting risk extrapolations.
Table 2 presents the results of the
International Agency for Research on
Cancer (IARC) international combined
analyses (5), carried out on 96,000 workers,
and compares them to estimates obtained
from IARC reanalyses ofthe atomic bomb
survivors data. As in the latter study, adose-
related increase in leukemia mortality has
been observed among nuclear industry
workers; the estimate of risk per unit of
radiation dose is intermediate between the
linear and linear-quadratic extrapolations
from atomic bomb survivors data (the latter
estimate is one ofthe bases for current radi-
ation protection recommendations). Given
the width ofthe confidence interval, how-
ever, the workers' estimate is also compati-
ble with a reduction ofrisk and with risks
twice the linear extrapolation from atomic
bomb survivors. The estimate for all other
cancers combined is close to zero, but, like
the leukemia estimate, the confidence inter-
val includes the extrapolation from atomic
bomb survivors.
The size of the estimated risk for
low-dose protracted exposures is relatively
small: the excessive relative risk (ERR) of
2.18/Sv for leukemia corresponds to a 22%
increased risk ofdying from leukemia for a
dose of 100 mSv received in a protracted
fashion. For comparison, although the cur-
rent recommendations ofthe International
Commission for Radiation Protection (15)
are to limit doses to 100 mSv over 5 years
for workers (and 1 mSv/year for the pub-
lic), only 8% ofthe 96,000 workers in the
Table 2. Comparison of estimates of excess relative risk (ERR) per Sv (and 90% Cl) between nuclear workers and
atomic bomb survivors.
All cancers except leukemia Leukemia excluding CLL
Population ERR/Sv 90% Cl ERR/Sv 90% Cl
Nuclearworkers dataa -0.07 (-0.39,0.30) 2.18 (0.13,53)
Atomic bomb,c linear 0.18 (0.05,0.34) 3.67 (2.0,6.5)
Atomic bomb, L-Qd 1.42 (<0,6.5)
Data from Cardis et al. (5). 'Adjusted for age, socioeconomic status, facility, and calendar time. bSimulated confi-
dence interval. cAtomic bomb survivors data adjusted for age, city, and calendartime; analyses carried out at IARC
(5). dBased on the linearterm of a linear-quadratic (L-Q) dose-response model in the atomic bomb survivors data.
combined data set received 100 mSv over
their entire careers. The estimated number
ofleukemia deaths attributed to radiation
exposure in this study was 9.7 (i.e., 8% of
all leukemia deaths).
The estimates presented here from the
combined analyses ofworker studies (5)
are the most comprehensive and precise
direct estimates obtained to date. Although
they are lower than the linear estimates
obtained from studies ofatomic bomb sur-
vivors, they are compatible with a range of
possibilities, from a reduction ofrisk at low
doses to risks twice those on which current
radiation protection recommendations are
based. Overall, however, the results ofthis
study do not suggest that current radiation
risk estimates for cancer at low levels of
exposure are appreciably in error.
There remains uncertainty concerning
the exact size of this risk, as indicated
by the width of the confidence intervals
presented. Further follow-up of these
cohorts and careful studies of additional
cohorts, such as those underway currendy
in 14 countries as part ofthe International
Collaborative Study ofCancer Risk among
Radiation Workers in the Nuclear
Industry (58,59), are needed to reduce the
uncertainty further.
Studies ofAccidental and
NonroutineExposures
Studies of other exposed populations,
particularly the populations exposed acci-
dentally, could also provide important
information to answer the outstanding
scientific and radiation protection ques-
tions. The effects ofprotracted exposures
could be examined in studies ofChernobyl
emergency accidentworkers and in popula-
tions living along the Techa River or
exposed as a result ofthe Kyshtym acci-
dent. The effects ofrelatively low doses,
such as those resulting from environmental
exposures in areas contaminated by the
Chernobyl accident; effects ofexposure to
different radionuclides and different types
ofradiation; and effects offactors that may
modify radiation induced risks could also
be studied.
To be informative, studies of acciden-
tally exposed populations must, like the
atomic bomb survivor and the nuclear
worker studies, fulfill several important cri-
teria: they must cover very large numbers
ofexposed subjects, the follow-up must be
complete and nonselective, and precise and
accurate individual dose estimates (or
markers ofexposure that are sensitive and
specific) must be available.
Several papers in the current session
cover aspects ofthe Chernobyl follow-up.
Given the levels ofenvironmental exposure
of the general population (Table 1), the
population movements that have taken
place since the accident, and in the absence
ofsystematic individual exposure estimates,
it is unlikely that a follow-up ofthe general
population living in contaminated territo-
ries will be very informative for radiation
risk estimation.
The observation of an early and dra-
matic increase in the number of thyroid
cancer cases in children (Table 3) in Belarus,
Ukraine and, more recently, in Russia
(60), however, may give important infor-
mation about host and environmental
factors that may modify the risk ofradia-
tion-induced cancer, in particular a possi-
ble genetic predisposition and stable iodine
status (61). Studies are being set up to
investigate this hypothesis.
Another potentially informative popu-
lation exposed to radiation as a result ofthe
Chernobyl accident is that ofthe clean-up
or emergency accident workers (Table 1).
Provided adequate estimates ofindividual
exposure can be derived, either by ques-
tionnaire from official dosimetry records or
by sensitive and specific biological markers,
studies of emergency accident workers
could provide important information on
the effect ofexposure rate and ofdifferent
radionuclides (62). Large-scale analytic
epidemiological studies of cancer risk
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Table 3. Distribution of thyroid cancer cases in children (under the age of 15 at diagnosis) in Belarus, Russia, and
in the Ukraine.
1981-1985 1986-1990 1991-1994
Location No. Rate No. Rate No. Rate
Belarus (whole country) 3 0.3 47 4.0 286 30.6
Gomel 1 0.5 21 10.5 143 96.4
Ukraine(whole country) 25 0.5 60 1.1 149 3.4
Five most northerly regions 1 0.1 21 2.0 97 11.5
Russia NA NA NA NA NA NA
Bryansk and Kaluga regions 0 0 3 1.2 20 10.0
NA, not available. Data from Stsjazhko et al. (60).
among these workers are now underway in
Baltic countries and are starting in Belarus,
Russia, and in the Ukraine.
Studies ofpopulations environmentally
exposed in the southern Urals (Table 1)
are also underway (63,64). Given the size
of the exposed populations and levels of
exposures, if cohort ascertainment and
follow-up can be systematic and complete
and ifreliable individual dose estimates can
be obtained, these studies will provide very
valuable information on the effects ofdose
protraction at different exposure levels and
for different radionuclides.
Conclusions
Although much is known concerning
risks associated with radiation exposure,
important scientific and radiation protec-
tion questions concerning radiation risks
remain. The study of survivors of the
atomic bombs dropped on Hiroshima and
Nagasaki in 1945 is currently the most
important single study ofradiation risks in
humans. Because ofthe nature ofthe expo-
sure, however, remaining questions con-
cerning exposure protraction, exposure
type, and some host and environmental
factors, which may modify radiation
risks, cannot be answered from studies of
the atomic bomb survivors and other high-
dose studies. Careful studies of other
populations, exposed accidentally or
occupationally, are therefore needed.
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